Association between the sarcopenia index and the risk of stroke in elderly patients with hypertension: a cohort study

The purpose of this study was to investigate the relationship between the sarcopenia index (SI) and stroke risk in elderly patients with hypertension. This study included 5145 stroke-free elderly hypertensive patients. We used Cox regression models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of incident stroke. Over a median follow-up of 38 months, we identified 607 (11.80%) individuals with total stroke, of whom 507 (9.85%) had ischemic stroke and 93 (1.81%) had hemorrhagic stroke. The risk of developing stroke decreased with each quartile of SI; after adjustment for multiple confounders, the HRs for the Q4 group versus the Q1 group were 0.46 (95% CI, 0.35–0.59) for total stroke, 0.46 (95% CI, 0.35–0.61) for ischemic stroke, and 0.33 (95% CI, 0.17–0.64) for hemorrhagic stroke. Restricted cubic spline analysis also demonstrated a cumulative increase in the risk of total stroke with decreases in the SI. The addition of SI to the conventional model for total stroke improved (ΔC-statistics = 0.02), an integrated discrimination improvement of 0.03 (95% CI, 0.02–0.04), and a net reclassification improvement of 0.17 (95% CI, 0.10–0.23). Similar results were observed for ischemic stroke and hemorrhagic stroke. This study found that elevated SI was negatively associated with the risk of stroke in elderly patients with hypertension. Uncovering the causality behind the relationship requires further prospective study.

[1]  Shasha Liu,et al.  Association between the geriatric nutritional risk index and the risk of stroke in elderly patients with hypertension: A longitudinal and cohort study , 2022, Frontiers in Nutrition.

[2]  H. Park,et al.  Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease , 2022, Frontiers in Nutrition.

[3]  Chenyu Sun,et al.  Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours , 2022, Frontiers in Nutrition.

[4]  Feng Yan,et al.  Prevalence of stroke in China, 2013–2019: A population-based study , 2022, The Lancet regional health. Western Pacific.

[5]  M. Fukui,et al.  Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes , 2022, BMJ Open Diabetes Research & Care.

[6]  Jiao-Jiao Bai,et al.  Current state of care for the elderly in China in the context of an aging population. , 2022, Bioscience trends.

[7]  Tianjiao Tang,et al.  Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer , 2022, Journal of cachexia, sarcopenia and muscle.

[8]  T. Oguri,et al.  Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis , 2022, BMC Pulmonary Medicine.

[9]  J. Shin Low serum creatinine to cystatin C ratio is independently associated with sarcopenia and high carotid plaque score in patients with type 2 diabetes. , 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  L. Cao,et al.  Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study , 2022, EClinicalMedicine.

[11]  J. Yue,et al.  Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis , 2022, Journal of cachexia, sarcopenia and muscle.

[12]  M. Naghavi,et al.  Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019 , 2021, The Lancet. Public health.

[13]  W. Tu,et al.  Aging tsunami coming: the main finding from China’s seventh national population census , 2021, Aging Clinical and Experimental Research.

[14]  K. Silay,et al.  Malnutrition-sarcopenia syndrome and all-cause mortality in hospitalized older people. , 2021, Clinical nutrition.

[15]  Xiping Xu,et al.  Plasma selenium and the risk of first stroke in adults with hypertension: a secondary analysis of the China Stroke Primary Prevention Trial. , 2021, The American journal of clinical nutrition.

[16]  Jiumei Cao,et al.  Sarcopenia predicts adverse outcomes in an elderly population with coronary artery disease: a systematic review and meta-analysis , 2021, BMC Geriatrics.

[17]  D. Koya,et al.  Autophagy in metabolic disease and ageing , 2021, Nature Reviews Endocrinology.

[18]  H. Liou,et al.  Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease , 2021, Scientific Reports.

[19]  C. Agatiello,et al.  Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[20]  P. Chau,et al.  The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression , 2021, Nutrients.

[21]  Shing‐Jong Lin,et al.  Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[22]  Y. Fujiwara,et al.  Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults , 2020, Journal of cachexia, sarcopenia and muscle.

[23]  S. Simpson,et al.  Branched chain amino acids, aging and age-related health , 2020, Ageing Research Reviews.

[24]  Shiying Yu,et al.  A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer. , 2020, Nutrition.

[25]  Hak Seung Lee,et al.  Sarcopenia Index as a Predictor of Clinical Outcomes in Older Patients with Coronary Artery Disease , 2020, Journal of clinical medicine.

[26]  M. Pizzimenti,et al.  Sarcopenia and peripheral arterial disease: a systematic review , 2020, Journal of cachexia, sarcopenia and muscle.

[27]  F. Goldwasser,et al.  Creatinine-to-cystatin C ratio and bioelectrical impedance analysis for the assessement of low lean body mass in cancer patients: Comparison to L3-computed tomography scan. , 2020, Nutrition.

[28]  Xin Gao,et al.  Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study. , 2020, Clinical nutrition.

[29]  B. Pedersen,et al.  Muscle–Organ Crosstalk: The Emerging Roles of Myokines , 2020, Endocrine reviews.

[30]  S. M. Barbalho,et al.  Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications , 2020, International journal of molecular sciences.

[31]  L. Peng,et al.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. , 2020, Journal of the American Medical Directors Association.

[32]  Tianjiao Tang,et al.  Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients , 2020, Scientific Reports.

[33]  D. Sedding,et al.  Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis , 2020, European heart journal.

[34]  K. Choi,et al.  Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences , 2020, International journal of molecular sciences.

[35]  P. Abete,et al.  Sarcopenia and Heart Failure , 2020, Nutrients.

[36]  K. Kohara,et al.  Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study. , 2020, Clinical nutrition.

[37]  Xiping Xu,et al.  A U-shaped association between serum betaine and incident risk of first ischemic stroke in hypertensive patients. , 2019, Clinical nutrition.

[38]  H. Liou,et al.  Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease. , 2019, Clinical nutrition.

[39]  C. Murray,et al.  Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet.

[40]  C. Kennedy,et al.  Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers. , 2019, Clinical nutrition.

[41]  Lin Wang,et al.  Prevalence and risk factors of stroke in the elderly in Northern China: data from the National Stroke Screening Survey , 2019, Journal of Neurology.

[42]  J. Viña,et al.  Sarcopenia, frailty and their prevention by exercise. , 2019, Free radical biology & medicine.

[43]  A. Rule,et al.  Sarcopenia Index Is a Simple Objective Screening Tool for Malnutrition in the Critically Ill. , 2018, JPEN. Journal of parenteral and enteral nutrition.

[44]  G. Shulman,et al.  Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.

[45]  Xiping Xu,et al.  Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients , 2018, Stroke.

[46]  L. Ferrucci,et al.  Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty , 2018, Nature Reviews Cardiology.

[47]  J. Batsis,et al.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies , 2018, Nature Reviews Endocrinology.

[48]  M. Fukui,et al.  Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes. , 2018, Diabetes research and clinical practice.

[49]  Hu Li,et al.  Senescent cells: a therapeutic target for cardiovascular disease , 2018, The Journal of clinical investigation.

[50]  Alan H. Daniels,et al.  Diagnostic Criteria and Clinical Outcomes in Sarcopenia Research: A Literature Review , 2018, Journal of clinical medicine.

[51]  C. Kennedy,et al.  The sarcopenia index: A novel measure of muscle mass in lung transplant candidates , 2018, Clinical transplantation.

[52]  R. Lindley Stroke Prevention in the Very Elderly. , 2018, Stroke.

[53]  V. Herasevich,et al.  Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index , 2017, Critical care medicine.

[54]  S. Bartels,et al.  Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey. , 2016, Clinical nutrition.

[55]  Yoosoo Chang,et al.  Relationship Between Low Relative Muscle Mass and Coronary Artery Calcification in Healthy Adults , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[56]  Luigi Ferrucci,et al.  Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. , 2014, The lancet. Diabetes & endocrinology.

[57]  M. Laakso,et al.  Insulin resistance and hyperglycaemia in cardiovascular disease development , 2014, Nature Reviews Endocrinology.

[58]  Yong-jun Choi,et al.  Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[59]  Misuzu Watanabe,et al.  Association between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in Japan. , 2012, Archives of gerontology and geriatrics.

[60]  Cuiying Wang,et al.  Sarcopenia in the elderly: Basic and clinical issues , 2012, Geriatrics & gerontology international.

[61]  M. Febbraio,et al.  Muscles, exercise and obesity: skeletal muscle as a secretory organ , 2012, Nature Reviews Endocrinology.

[62]  G. Paolisso,et al.  Discovering pathways of sarcopenia in older adults: A role for insulin resistance on mitochondria dysfunction , 2011, The journal of nutrition, health & aging.

[63]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[64]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[65]  A. Murray,et al.  Kidney Function and Sarcopenia in the United States General Population: NHANES III , 2007, American Journal of Nephrology.

[66]  M. Parmacek,et al.  Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. , 2007, Circulation research.

[67]  V. Montori,et al.  Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies , 2006, The Lancet.

[68]  H. Quan,et al.  New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.

[69]  Suzanne G. Leveille,et al.  Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum Levels , 2002, Journal of the American Geriatrics Society.

[70]  T. Rice,et al.  Heart rate and blood pressure changes with endurance training: the HERITAGE Family Study. , 2001, Medicine and science in sports and exercise.